Research Grants Awarded

Reseach grants support Minnesota scientific and medical research that has the potential to translate to clinical advances in regenerative medicine. Grants typically open every September. Learn more about how to apply for a grant by reading our frequently asked questions. 

 

View research grants awarded by year.
image of Nathan P. Staff, MD, PhD
Nathan P. Staff, MD, PhD
A Phase IIA study using intrathecal treatment of autologous adipose-derived mesenchymal stem cells for amyotrophic lateral sclerosis
The overall objective of this proposal is to conduct a multi-site, placebo-controlled Phase IIA clinical trial to obtain clinical data on the…
2016-2018
image of Ann M. Parr, MD, PhD
Ann M. Parr, MD, PhD
Generating human neural stem and progenitor cells in a porcine model through blastocyst complementation
Porcine blastocyst complementation utilizing human pluripotent stem cells (hPSCs) is a potentially transformative approach that could generate…
2016-2018
image of Kimberly Holst, MD
Kimberly Holst, MD
Phase I study of delivery of autologous bone marrow derived mononuclear cells to myopathic right ventricle in patients with Ebstein anomaly during surgical intervention
The goal of this Phase I study is to establish the safety and feasibility of intramyocardial injection of autologous bone marrow derived…
2016-2018
image of Daniel J. Garry, MD, PhD
Daniel J. Garry, MD, PhD
Humanized vasculature in gene edited animals
The long term goal of our research proposal is to generate a human organ (vasculature) in pigs, which will serve as an unlimited source of vessels…
2016-2018
image of Brian Fife, PhD
Brian Fife, PhD
Identifying and targeting antigen specific T cells in diabetes to preserve beta cells
The primary goals of this project are to restore immune homeostasis that allows islet beta cell survival and regeneration as a cure for Type 1…
2016-2018
image of John C. Burnett, Jr, MD
John C. Burnett, Jr, MD
Novel Cell-Free Peptide Therapeutics for Cardiac Repair and Regeneration
  Our goal is to establish that the use of a novel Mayo Clinic engineered peptide will serve as an innovative cell-free peptide therapeutic strategy…
2016-2018
image of Jonathan S. Marchant, PhD
Jonathan S. Marchant, PhD
Addressing the source of Parkinson's disease
There is a key need to generate new drug treatments for neurodegenerative diseases that stop disease progression rather than just mask symptoms. In…
2016-2018
image of Bruce Blazar, MD
Bruce Blazar, MD
Reducing recovery time after bone marrow transplant
Bone marrow transplants (BMTs) help thousands of patients with various diseases and cancers, such as leukemia and lymphoma. Patients receive…
2016-2018
image of Bruce Walcheck, PhD
Bruce Walcheck, PhD
Treating cancer using the patient's immune system
Cancer is a difficult disease to treat because it is hard to detect within the body. Cancer sneaks in to normal cells and changes them to cancer…
2015-2017
image of Dr. Elizabeth W. Bradley
Elizabeth W. Bradley, PhD
Repair & regeneration of human cartilage damaged by osteoarthritis
Osteoarthritis is one of the leading causes of disability in the US today. The disease occurs when articular cartilage in a joint degenerates.…
2015-2017
image of Deborah Ferrington
Deborah Ferrington, PhD
Faster testing of treatments for age-related macular degeneration
Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, affecting about 15 million people in the United States.…
2015-2017
image of Scott L. Nyberg, MD, PhD
Scott L. Nyberg, MD, PhD
A Second Chance for More Liver Patients
For many patients with acute liver failure (ALF), the only option for a cure is a liver transplant. ALF is contracted when a normally healthy liver…
2015-2017